PubRank

W Robb MacLellan

Author PubWeight™ 49.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev 2007 3.41
2 Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002 2.97
3 Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003 1.90
4 Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells 2008 1.83
5 Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A 2010 1.74
6 Regulation of the mammalian cell cycle: a model of the G1-to-S transition. Am J Physiol Cell Physiol 2002 1.58
7 Dynamics of the cell cycle: checkpoints, sizers, and timers. Biophys J 2003 1.47
8 Cyclin-dependent kinase 2 signaling regulates myocardial ischemia/reperfusion injury. J Mol Cell Cardiol 2008 1.44
9 Regulation of RNA polymerase III transcription during hypertrophic growth. EMBO J 2006 1.42
10 Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J Am Coll Cardiol 2004 1.41
11 Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2-dependent pathway. EMBO J 2006 1.41
12 Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration. J Neurosci 2011 1.36
13 Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 2005 1.32
14 Human adipose stem cells: a potential cell source for cardiovascular tissue engineering. Cells Tissues Organs 2008 1.20
15 Effects of a home-based exercise program on clinical outcomes in heart failure. Am Heart J 2007 1.18
16 Optimized preservation of extracellular matrix in cardiac tissues: implications for long-term graft durability. Ann Thorac Surg 2007 1.15
17 "Good enough solutions" and the genetics of complex diseases. Circ Res 2012 1.13
18 Multisite phosphorylation and network dynamics of cyclin-dependent kinase signaling in the eukaryotic cell cycle. Biophys J 2004 1.12
19 Analysis of oxygen transport in a diffusion-limited model of engineered heart tissue. Biotechnol Bioeng 2007 1.08
20 Quantitative second harmonic generation imaging of cartilage damage. Cell Tissue Bank 2008 1.07
21 Abcc6 deficiency causes increased infarct size and apoptosis in a mouse cardiac ischemia-reperfusion model. Arterioscler Thromb Vasc Biol 2011 1.02
22 Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways. Proc Natl Acad Sci U S A 2002 1.02
23 Coordination of cell growth and cell division: a mathematical modeling study. J Cell Sci 2004 0.99
24 A cyclin D2-Rb pathway regulates cardiac myocyte size and RNA polymerase III after biomechanical stress in adult myocardium. Circ Res 2008 0.98
25 Increased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjögren's syndrome. Matrix Biol 2007 0.97
26 Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells. PLoS One 2012 0.95
27 Influence of systematically varied nano-scale topography on cell morphology and adhesion. Cell Commun Adhes 2007 0.94
28 Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease. Circulation 2003 0.92
29 Epigenetic regulation of myogenic gene expression by heterochromatin protein 1 alpha. PLoS One 2013 0.90
30 EID-2, a novel member of the EID family of p300-binding proteins inhibits transactivation by MyoD. Gene 2003 0.87
31 Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Cell Transplant 2005 0.83
32 Hysteresis and cell cycle transitions: how crucial is it? Biophys J 2004 0.83
33 Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery. Adv Drug Deliv Rev 2011 0.81
34 Cardiopoietry in motion: primed mesenchymal stem cells for ischemic cardiomyopathy. J Am Coll Cardiol 2013 0.81
35 Atorvastatin and statins in the treatment of heart failure. Expert Opin Pharmacother 2007 0.80
36 Relative roles of heart transplantation and long-term mechanical circulatory support in contemporary management of advanced heart failure - a critical appraisal 10 years after REMATCH. Eur J Cardiothorac Surg 2011 0.80
37 Regeneration potential of adult cardiac myocytes. Cell Res 2013 0.79
38 Risk stratification in patients with advanced heart failure requiring biventricular assist device support as a bridge to cardiac transplantation. J Heart Lung Transplant 2012 0.78
39 Outcomes of biventricular mechanical support patients discharged to home to await heart transplantation. J Cardiovasc Nurs 2015 0.76
40 Induced pluripotent stem cells: it's like déjà vu all over again. Circulation 2009 0.76
41 Heart disease leaves its mark: proteomics-based biosignatures in acute coronary syndromes. J Am Coll Cardiol 2004 0.76
42 Dilated cardiomyopathy: learning to live with yourself. Nat Med 2003 0.76
43 Microenvironment influences vascular differentiation of murine cardiovascular progenitor cells. J Biomed Mater Res B Appl Biomater 2014 0.75
44 Corrigendum: Epigenomic Reprogramming of Adult Cardiomyocyte-Derived Cardiac Progenitor Cells. Sci Rep 2017 0.75